Atlas Trials

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Clinical trial NCT01289821 · COMPLETED

Trial details

NCT number
NCT01289821
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Neoplasms
Start date
2011-02-01
Primary completion
2012-03-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.